Drug Industry Daily
July 27, 2012
| Vol.
11 No.
147
Qualitest Gets FDA Green Light for Generic Keppra
The FDA has approved Qualitest Pharmaceuticals’ ANDA for extended-release levetiracetam tablets, the generic equivalent of UCB’s anti-epileptic med Keppra.
This article is viewable by subscribers only. To view this article, please select an option below.
|